INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 36 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,815,000 | -35.7% | 879,000 | +8.7% | 0.46% | -36.0% |
| Q1 2019 | $5,930,000 | -28.9% | 809,000 | -26.9% | 0.71% | -37.1% |
| Q4 2018 | $8,341,000 | +25.4% | 1,106,175 | -6.0% | 1.13% | +60.6% |
| Q3 2018 | $6,649,000 | +69.7% | 1,176,775 | +32.2% | 0.71% | +61.2% |
| Q2 2018 | $3,918,000 | +37.3% | 890,386 | +97.3% | 0.44% | +39.9% |
| Q1 2018 | $2,854,000 | +56.1% | 451,252 | +27.1% | 0.31% | +37.3% |
| Q4 2017 | $1,828,000 | -42.5% | 355,000 | 0.0% | 0.23% | -44.3% |
| Q3 2017 | $3,177,000 | – | 355,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |